"Virginia Endocrinology Research conducts medical research trials for leading pharmaceutical and biotechnology companies. Our projects help expand the frontiers of endocrinology and diabetes medicine to help ensure that people receive safe and effective treatments, using volunteers with health conditions specific to each study. Led by endocrinologist Dr. James LaRocque, our goal is to match our strengths as healthcare providers with the people and technology that lead to a healthier future for us all. Dr. LaRocque has over 30 years experience in Internal, Endocrinology and Metabolic Medicine. He is supported by a team of highly qualified and experienced Endocrinology Nurse Practitioners & Clinical Research Coordinators."

During the past decade, Virginia Endocrinology Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Endocrinology Research" #1 sponsor was "Novartis Pharmaceuticals" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "RECORDATI GROUP" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Endocrinology Research" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Endocrinology Research" are "Acromegaly" (2 trials), "Dumping Syndrome" (2 trials), "Cushing's Disease" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetic Kidney Disease" (1 trials). Many other conditions were trialed in "Virginia Endocrinology Research" in a lesser frequency.

Most popular intervention types in "Virginia Endocrinology Research" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BMS-813160" (1 trials), "Cabergoline" (1 trials), "Empagliflozin" (1 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Endocrinology Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Virginia Endocrinology Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Virginia Endocrinology Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Endocrinology Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".